InsiderTrades

Form 4 for PFE Pfizer

Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-25 · accession 0001225208-23-002983 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-28 2023-02-25 PFE JOHNSON RADY A EVP F - Tax $42.86 -22.8K 108.6K -17% -$978.7K
D 2023-02-28 2023-02-25 PFE JOHNSON RADY A EVP M - OptEx $22.89 +33.7K 116.5K +41% +$770.3K
D 2023-02-28 2023-02-25 PFE JOHNSON RADY A EVP M - OptEx $0.00 -33.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-25 F D 14,966 $43.44 93,637 D — — (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
2 Common Common Stock 2023-02-25 F D 7,870 $41.75 108,603 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 24, 2023.
3 Common Common Stock 2023-02-25 M A 33,654 $22.89 116,473 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
4 Derivative Stock Appreciation Rights 2023-02-25 M D 33,654 $0.00 0 D $22.89 · 2023-02-25 to 2023-02-25 33,654 Common Stock